Synthesis of 11C-Labeled RXR Partial Agonist 1-[(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)amino]benzotriazole-5-carboxylic Acid (CBt-PMN) by Direct [11C]Carbon Dioxide Fixation via Organolithiation of Trialkyltin Precursor and PET Imaging Thereof. 2017

Osamu Shibahara, and Masaki Watanabe, and Shoya Yamada, and Masaru Akehi, and Takanori Sasaki, and Akiya Akahoshi, and Takahisa Hanada, and Hiroyuki Hirano, and Shunsuke Nakatani, and Hiromi Nishioka, and Yasuo Takeuchi, and Hiroki Kakuta
Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , 1-1-1, Tsushima-Naka, Kita-Ku, Okayama 700-8530, Japan.

The retinoid X receptor (RXR) partial agonist 1-[(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)amino]benzotriazole-5-carboxylic acid (1; CBt-PMN, Emax = 75%, EC50 = 143 nM) is a candidate for treatment of central nervous system (CNS) diseases such as Alzheimer's and Parkinson's diseases based on reports that RXR-full agonist 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic acid (bexarotene) shows therapeutic effects on these disease in rodent models. Here, we synthesized carbon-11-labeled ([11C]1) as a tracer for positron emission tomography (PET) and used it in a PET imaging study to examine the brain uptake and biodistribution of 1. We found that 11CO2 fixation after tin-lithium exchange at -20 °C afforded [11C]1. This methodology may also be useful for synthesizing 11CO2H-PET tracer derivatives of other compounds bearing π-rich heterocyclic rings. A PET/CT imaging study of [11C]1 in mice indicated 1 is distributed to the brain and is thus a candidate for treatment of CNS diseases.

UI MeSH Term Description Entries
D008094 Lithium An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER. Lithium-7,Lithium 7
D008297 Male Males
D008813 Mice, Inbred ICR An inbred strain of mouse that is used as a general purpose research strain, for therapeutic drug testing, and for the genetic analysis of CARCINOGEN-induced COLON CANCER. Mice, Inbred ICRC,Mice, ICR,Mouse, ICR,Mouse, Inbred ICR,Mouse, Inbred ICRC,ICR Mice,ICR Mice, Inbred,ICR Mouse,ICR Mouse, Inbred,ICRC Mice, Inbred,ICRC Mouse, Inbred,Inbred ICR Mice,Inbred ICR Mouse,Inbred ICRC Mice,Inbred ICRC Mouse
D009947 Organotin Compounds Organic compounds which contain tin in the molecule. Used widely in industry and agriculture. Compounds, Organotin
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002245 Carbon Dioxide A colorless, odorless gas that can be formed by the body and is necessary for the respiration cycle of plants and animals. Carbonic Anhydride,Anhydride, Carbonic,Dioxide, Carbon
D002250 Carbon Radioisotopes Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes. Radioisotopes, Carbon
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001345 Autoradiography The making of a radiograph of an object or tissue by recording on a photographic plate the radiation emitted by radioactive material within the object. (Dorland, 27th ed) Radioautography
D013764 Tetrahydronaphthalenes Partially saturated 1,2,3,4-tetrahydronaphthalene compounds. Tetralins

Related Publications

Osamu Shibahara, and Masaki Watanabe, and Shoya Yamada, and Masaru Akehi, and Takanori Sasaki, and Akiya Akahoshi, and Takahisa Hanada, and Hiroyuki Hirano, and Shunsuke Nakatani, and Hiromi Nishioka, and Yasuo Takeuchi, and Hiroki Kakuta
March 2013, Journal of medicinal chemistry,
Osamu Shibahara, and Masaki Watanabe, and Shoya Yamada, and Masaru Akehi, and Takanori Sasaki, and Akiya Akahoshi, and Takahisa Hanada, and Hiroyuki Hirano, and Shunsuke Nakatani, and Hiromi Nishioka, and Yasuo Takeuchi, and Hiroki Kakuta
October 2016, Journal of medicinal chemistry,
Osamu Shibahara, and Masaki Watanabe, and Shoya Yamada, and Masaru Akehi, and Takanori Sasaki, and Akiya Akahoshi, and Takahisa Hanada, and Hiroyuki Hirano, and Shunsuke Nakatani, and Hiromi Nishioka, and Yasuo Takeuchi, and Hiroki Kakuta
October 2009, Journal of medicinal chemistry,
Osamu Shibahara, and Masaki Watanabe, and Shoya Yamada, and Masaru Akehi, and Takanori Sasaki, and Akiya Akahoshi, and Takahisa Hanada, and Hiroyuki Hirano, and Shunsuke Nakatani, and Hiromi Nishioka, and Yasuo Takeuchi, and Hiroki Kakuta
January 2019, Nuclear medicine and biology,
Osamu Shibahara, and Masaki Watanabe, and Shoya Yamada, and Masaru Akehi, and Takanori Sasaki, and Akiya Akahoshi, and Takahisa Hanada, and Hiroyuki Hirano, and Shunsuke Nakatani, and Hiromi Nishioka, and Yasuo Takeuchi, and Hiroki Kakuta
January 1988, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology,
Osamu Shibahara, and Masaki Watanabe, and Shoya Yamada, and Masaru Akehi, and Takanori Sasaki, and Akiya Akahoshi, and Takahisa Hanada, and Hiroyuki Hirano, and Shunsuke Nakatani, and Hiromi Nishioka, and Yasuo Takeuchi, and Hiroki Kakuta
November 2021, International journal of molecular sciences,
Osamu Shibahara, and Masaki Watanabe, and Shoya Yamada, and Masaru Akehi, and Takanori Sasaki, and Akiya Akahoshi, and Takahisa Hanada, and Hiroyuki Hirano, and Shunsuke Nakatani, and Hiromi Nishioka, and Yasuo Takeuchi, and Hiroki Kakuta
November 2013, Journal of medicinal chemistry,
Osamu Shibahara, and Masaki Watanabe, and Shoya Yamada, and Masaru Akehi, and Takanori Sasaki, and Akiya Akahoshi, and Takahisa Hanada, and Hiroyuki Hirano, and Shunsuke Nakatani, and Hiromi Nishioka, and Yasuo Takeuchi, and Hiroki Kakuta
September 1996, Journal of medicinal chemistry,
Osamu Shibahara, and Masaki Watanabe, and Shoya Yamada, and Masaru Akehi, and Takanori Sasaki, and Akiya Akahoshi, and Takahisa Hanada, and Hiroyuki Hirano, and Shunsuke Nakatani, and Hiromi Nishioka, and Yasuo Takeuchi, and Hiroki Kakuta
September 2012, ChemMedChem,
Osamu Shibahara, and Masaki Watanabe, and Shoya Yamada, and Masaru Akehi, and Takanori Sasaki, and Akiya Akahoshi, and Takahisa Hanada, and Hiroyuki Hirano, and Shunsuke Nakatani, and Hiromi Nishioka, and Yasuo Takeuchi, and Hiroki Kakuta
February 1977, Archiv der Pharmazie,
Copied contents to your clipboard!